In Reply We thank Singh et al for their comments on our article1 demonstrating the benefits of specialist neurology and comprehensive epilepsy care on mortality in patients with epilepsy. We agree that evidence-based care should be driven by data. In a global environment of accelerating health care costs,2 the same methods should be used to demonstrate value for money. However, it may be unsurprising that bespoke care improves outcomes; particularly pertinent for countries offering universal health coverage, the unequivocal demonstration of benefit is an indispensable prerequisite for advocates of the judicious use of finite health care resources. Our study clearly demonstrates said value as referral to a comprehensive epilepsy program (hazard ratio, 0.49; 95% CI, 0.38-0.62) robustly reduces premature mortality,1 a problem that contributes to epilepsy existing as the third most common neurological cause of years lived with disability in the world.3